Declining mortality from adult pneumococcal infections linked to children's vaccination - 09/03/16
, Carmen Ardanuy b , Meritxell Cubero b , Miguel A. Benitez c , Josefina Liñares b , Roman Pallares a, ⁎ Summary |
Objective |
To determine changes in mortality among adults with invasive pneumococcal disease (IPD) after introducing pneumococcal conjugate vaccines (PCVs) in children.
Methods |
An active surveillance of adults with culture-proven IPD in Barcelona. Serotype-specific mortality and rates of disease and death were analysed in three periods: baseline (1994–2001), PCV7 (2002–2009) and PCV13 (2010–2013).
Results |
Overall, IPD caused by PCV7 serotypes was associated with increased case fatality rate (24 percent).
In patients 18–64 years (baseline vs. PCV7 vs. PCV13 periods), case fatality rate from IPD decreased (22 vs.14 vs. 12 percent), and it was associated with a decline in PCV7 serotypes (3.56 vs. 2.80 vs. 1.49 cases/105 person-years) and in PCV7 serotypes-specific death (0.74 vs. 0.53 vs. 0.09 deaths/105 person-years).
In patients ≥65 years, case fatality rate did not change (24 vs. 22 vs. 24 percent); however, there was a decline in PCV7 serotypes-specific death (4.94 vs. 3.58 vs. 2.45 deaths/105 person-years), and an increase in non-PCV serotypes-specific death (2.55 vs. 3.70 vs. 4.09 deaths/105 person-years).
Conclusions |
The use of PCVs for children was associated with a reduction of mortality from IPD in adults 18–64 years, through the indirect effect of herd protection. In older adults, age-related factors could play a role in IPD mortality.
Le texte complet de cet article est disponible en PDF.Highlights |
• | The use of PCVs for children has been associated with a decrease of adult invasive pneumococcal disease (IPD) rates by the effect of herd protection. |
• | PCV7 serotypes were associated with high case fatality rate in adults with IPD. |
• | An additional indirect benefit of paediatric PCV was a decline in adult IPD mortality linked to a decrease of PCV7 serotypes-specific death. |
Keywords : Streptococcus pneumoniae, Pneumonia, Serotypes, Mortality, Pneumococcal vaccines
Plan
Vol 72 - N° 4
P. 439-449 - avril 2016 Retour au numéro
Article précédent
- The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults
- F. McGill, R.S. Heyderman, B.D. Michael, S. Defres, N.J. Beeching, R. Borrow, L. Glennie, O. Gaillemin, D. Wyncoll, E. Kaczmarski, S. Nadel, G. Thwaites, J. Cohen, N.W.S. Davies, A. Miller, A. Rhodes, R.C. Read, T. Solomon
- Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG
- Mark Reglinski, Nicola N. Lynskey, Yoon Jung Choi, Robert J. Edwards, Shiranee Sriskandan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?